Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $9,720 - $12,625
-372 Reduced 5.08%
6,951 $200,000
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $11,937 - $13,953
372 Added 5.35%
7,323 $243,000
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $793,592 - $918,168
-21,971 Reduced 75.97%
6,951 $255,000
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $12,210 - $15,896
-310 Reduced 1.06%
28,922 $1.18 Million
Q4 2022

Jan 11, 2023

BUY
$41.75 - $54.5 $60,120 - $78,480
1,440 Added 5.18%
29,232 $1.5 Million
Q3 2022

Oct 13, 2022

SELL
$43.76 - $53.42 $67,828 - $82,801
-1,550 Reduced 5.28%
27,792 $1.22 Million
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $303,422 - $359,763
6,521 Added 28.57%
29,342 $1.54 Million
Q1 2022

Apr 26, 2022

BUY
$45.75 - $56.69 $39,802 - $49,320
870 Added 3.96%
22,821 $1.78 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $126,439 - $187,425
-3,060 Reduced 12.23%
21,951 $1.3 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $4,906 - $6,302
-125 Reduced 0.5%
25,011 $1.08 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $52,428 - $59,392
-1,460 Reduced 5.49%
25,136 $984,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $73,008 - $82,338
-2,180 Reduced 7.58%
26,596 $964,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $12,049 - $15,321
360 Added 1.27%
28,776 $1.06 Million
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $86,360 - $101,320
-2,720 Reduced 8.74%
28,416 $1.04 Million
Q2 2020

Jul 21, 2020

SELL
$30.12 - $36.54 $93,673 - $113,639
-3,110 Reduced 9.08%
31,136 $1.02 Million
Q1 2020

Apr 24, 2020

SELL
$27.03 - $38.62 $93,064 - $132,968
-3,443 Reduced 9.14%
34,246 $1.12 Million
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $1.24 Million - $1.41 Million
37,689 New
37,689 $1.48 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cairn Investment Group, Inc. Portfolio

Follow Cairn Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.